Comparison effect of addition Dexmedetomidine and Metoprolol to Tiopntal ?on hydrodynamic responses, agitation and patients satisfaction in electro ?convulsive therapy for patients with mood disorder

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N87

Enrollment

Registered

2018-10-31

Start date

2018-05-20

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mood disorder. Mood disorder due to known physiological condition

Interventions

Intervention 1: Intervention group: We inject 0/5 micro gram in kilogram Dexmedetomidin before intubation in first group. Intervention 2: Intervention group: We inject 2/5 milligram Metoral 10 minute

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: All patients with cognitive dysfunction receive ECT 18 to 60 years

Exclusion criteria

Exclusion criteria: All patients with anesthesia induced cardiac arrest during ECT All patients who after ECT due to long-term apnea and respiratory distress need to intubation. All patients who don't have seizures during the ECT process.

Design outcomes

Primary

Measure	Time frame
Mean of blood pressure. Timepoint: Before and after electro convulsive therapy. Method of measurement: Barometer.;Heart rate. Timepoint: Before and after electro convulsive therapy. Method of measurement: count.;Degree of restlessness. Timepoint: After electro convulsive therapy. Method of measurement: Agitation ?score.;Degree of satisfaction. Timepoint: After electro convulsive therapy. Method of measurement: satisfaction score.;Duration of seizure. Timepoint: After electro convulsive therapy. Method of measurement: Minute.	—

Measure

Time frame

Mean of blood pressure. Timepoint: Before and after electro convulsive therapy. Method of measurement: Barometer.;Heart rate. Timepoint: Before and after electro convulsive therapy. Method of measurement: count.;Degree of restlessness. Timepoint: After electro convulsive therapy. Method of measurement: Agitation ?score.;Degree of satisfaction. Timepoint: After electro convulsive therapy. Method of measurement: satisfaction score.;Duration of seizure. Timepoint: After electro convulsive therapy. Method of measurement: Minute.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 68 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026